Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 3/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.37 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.34 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9406923 | 0.91 | TRPV4 (0.40) | CYP11B1CYP11B2TRPV4 | |
| SCHEMBL9406918 | 0.91 | TRPV4 (0.40) | CYP11B1CYP11B2TRPV4 | |
| SCHEMBL15488942 | 0.87 | CYP11B1 (0.31) | CYP11B1CYP11B2 | |
| SCHEMBL15180939 | 0.84 | CYP11B1 (0.31) | CYP11B1CYP11B2 | |
| SCHEMBL30332276 | 0.83 | CYP11B1 (0.32) | CYP11B1CYP11B2TRPV4PDE4APDE4B | |
| SCHEMBL13002705 | 0.79 | CYP11B1 (0.33) | CYP11B1CYP11B2 | |
| SCHEMBL14749542 | 0.79 | — | — | |
| SCHEMBL14235166 | 0.79 | — | — | |
| SCHEMBL15180942 | 0.78 | CYP11B1 (0.34) | CYP11B1CYP11B2 | |
| SCHEMBL9407073 | 0.78 | TRPV4 (0.34) | CYP11B1CYP11B2TRPV4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023232753-A1 | FERROELECTRIC SMECTIC LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-12-07 | — | — | WO | disclosed |
| WO-2023232754-A1 | FERROELECTRIC NEMATIC LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-12-07 | — | — | WO | disclosed |